TAMOXIFEN SCP tamoxifen (as citrate) 20 mg tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

tamoxifen citrate, Quantity: 30.34 mg (Equivalent: tamoxifen, Qty 20 mg)

제공처:

Southern Cross Pharma Pty Ltd

약제 형태:

Tablet

구성:

Excipient Ingredients: brilliant scarlet 4R; maize starch; lactose monohydrate; magnesium stearate; povidone

관리 경로:

Oral

패키지 단위:

60, 30

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Treatment of breast cancer TAMOXIFEN SCP is indicated for the treatment of breast cancer.,Primary reduction of breast cancer risk TAMOXIFEN SCP is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

제품 요약:

Visual Identification: Pink, round biconvex tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Registered

승인 날짜:

2020-07-24